Transjugular Intrahepatic Portosystemic Shunt for the Treatment of Chylothorax and Chylous Ascites in Cirrhosis: A Case Report and Systematic Review of the Literature
- PMID: 26723922
- DOI: 10.1016/j.jvir.2015.09.022
Transjugular Intrahepatic Portosystemic Shunt for the Treatment of Chylothorax and Chylous Ascites in Cirrhosis: A Case Report and Systematic Review of the Literature
Abstract
Cirrhosis-related chylothorax and chylous ascites are rare conditions. The pathophysiologic mechanism of cirrhosis-related chylous fluid collections is believed to be excessive lymph flow resulting from portal hypertension. Transjugular intrahepatic portosystemic shunt (TIPS) creation is a well-established method for reducing portal hypertension. The case of a 61-year-old man with cirrhosis-related chylothorax treated successfully with a TIPS is described. A systematic review of the literature revealed nine additional cases of chylothorax or chylous ascites treated successfully with a TIPS. These cases showed that TIPS creation may be effective and safe for the treatment of chylous fluid collections in patients with cirrhosis.
Copyright © 2016 SIR. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Portal Venous Decompression for Treatment of Portal Hypertension-Related Refractory Chylous Ascites or Chylothorax.J Vasc Interv Radiol. 2025 Aug;36(8):1336-1340. doi: 10.1016/j.jvir.2025.04.014. Epub 2025 Apr 28. J Vasc Interv Radiol. 2025. PMID: 40306615
-
Transjugular intrahepatic portosystemic shunt creation as treatment for refractory chylous ascites and chylothorax in a patient with cirrhosis.J Vasc Interv Radiol. 2004 Jan;15(1 Pt 1):85-9. doi: 10.1097/01.rvi.0000106391.63463.4c. J Vasc Interv Radiol. 2004. PMID: 14709693
-
Transjugular intrahepatic portosystemic shunt for treatment of cirrhosis-related chylothorax and chylous ascites: single-institution retrospective experience.Cardiovasc Intervent Radiol. 2013 Aug;36(4):992-7. doi: 10.1007/s00270-012-0530-x. Epub 2012 Dec 4. Cardiovasc Intervent Radiol. 2013. PMID: 23207657
-
The Impact of Transjugular Intrahepatic Portosystemic Shunt on Nutrition in Liver Cirrhosis Patients: A Systematic Review.Nutrients. 2023 Mar 27;15(7):1617. doi: 10.3390/nu15071617. Nutrients. 2023. PMID: 37049459 Free PMC article.
-
Sarcopenia is a risk factor for post-transjugular intrahepatic portosystemic shunt hepatic encephalopathy and mortality: A systematic review and meta-analysis.Indian J Gastroenterol. 2024 Aug;43(4):748-759. doi: 10.1007/s12664-023-01465-2. Epub 2023 Dec 12. Indian J Gastroenterol. 2024. PMID: 38085501
Cited by
-
Splenic vein stenting for recurrent chylous ascites in sinistral portal hypertension: a case report.CVIR Endovasc. 2021 Mar 3;4(1):26. doi: 10.1186/s42155-021-00213-x. CVIR Endovasc. 2021. PMID: 33656619 Free PMC article.
-
Transjugular intrahepatic portosystemic shunt in cirrhosis: An exhaustive critical update.World J Gastroenterol. 2020 Oct 7;26(37):5561-5596. doi: 10.3748/wjg.v26.i37.5561. World J Gastroenterol. 2020. PMID: 33088154 Free PMC article. Review.
-
Chylothorax as a complication of extensive spontaneous left arm DVT.BMJ Case Rep. 2019 Dec 30;12(12):e232563. doi: 10.1136/bcr-2019-232563. BMJ Case Rep. 2019. PMID: 31892625 Free PMC article.
-
Management of chylous ascites after liver cirrhosis: A case report.World J Hepatol. 2025 Jan 27;17(1):100797. doi: 10.4254/wjh.v17.i1.100797. World J Hepatol. 2025. PMID: 39871904 Free PMC article.
-
Transudative chylothorax and frailty: a diagnostic and therapeutic challenge.BMJ Case Rep. 2023 May 23;16(5):e252439. doi: 10.1136/bcr-2022-252439. BMJ Case Rep. 2023. PMID: 37221001 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical